Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,005
Closed -$98.1K 2769
2025
Q3
$98.1K Sell
1,005
-10,612
-91% -$855K ﹤0.01% 2606
2025
Q2
$810K Buy
11,617
+5,398
+87% +$308K ﹤0.01% 1909
2025
Q1
$309K Buy
6,219
+5,216
+520% +$330K ﹤0.01% 2269
2024
Q4
$70.1K Buy
+1,003
New +$83.3K ﹤0.01% 2792

Other funds holding ACLS

PEAK6's ACLS Position: Q4 2025 in Review

PEAK6 sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 1,005 shares — an estimated $98.1K sold.

PEAK6 first reported a position in ACLS in Q4 2024 and held it in 4 quarters. The position peaked at $810K in Q2 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • PEAK6 reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • PEAK6 sold 1,005 Axcelis shares in Q4 2025, an estimated $98.1K.
  • PEAK6 first reported a position in Axcelis in Q4 2024 and held it in 4 quarters.
  • PEAK6's Axcelis position peaked at $810K in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.